dc.contributor.author | Turnbull, C | |
dc.contributor.author | Loveday, C | |
dc.contributor.author | Izatt, L | |
dc.contributor.author | Ellard, S | |
dc.date.accessioned | 2020-09-30T13:36:29Z | |
dc.date.issued | 2018-09-01 | |
dc.identifier.citation | The Journal of clinical endocrinology and metabolism, 2018, 103 (9), pp. 3518 - 3519 | |
dc.identifier.issn | 0021-972X | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4102 | |
dc.identifier.eissn | 1945-7197 | |
dc.identifier.doi | 10.1210/jc.2018-01094 | |
dc.format | Print | |
dc.format.extent | 3518 - 3519 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ENDOCRINE SOC | |
dc.subject | Humans | |
dc.subject | Thyroid Neoplasms | |
dc.subject | Mutation | |
dc.subject | Proto-Oncogene Proteins c-ret | |
dc.title | Response to Letter to the Editor: "p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer". | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2018-07-12 | |
rioxxterms.versionofrecord | 10.1210/jc.2018-01094 | |
rioxxterms.licenseref.startdate | 2018-09 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | The Journal of clinical endocrinology and metabolism | |
pubs.issue | 9 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR | |
pubs.publication-status | Published | |
pubs.volume | 103 | |
pubs.embargo.terms | Not known | |
dc.contributor.icrauthor | Turnbull, Clare | |